AMERIPRISE FINANCIAL INC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 820027
MINNEAPOLIS, MN
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,708,060
+$728,976 QoQ
Shares Held
155,908
-18.4% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 93%
None 7%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. ARWR ranks #53 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,708,060 | 155,908 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $11,979,084 | 191,054 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,093,897 | 257,477 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $9,455,881 | 274,163 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,219,026 | 267,027 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,646,582 | 286,231 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,229,774 | 224,988 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,246,987 | 219,256 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,185,817 | 738,200 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $28,522,692 | 997,297 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $28,415,158 | 928,600 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $18,637,460 | 693,616 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $16,094,748 | 451,339 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $11,843,460 | 466,278 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $20,508,554 | 505,635 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $17,542,046 | 530,773 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,951,181 | 538,233 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $24,656,663 | 536,131 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $36,078,602 | 544,172 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $30,977,577 | 496,197 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $41,257,857 | 498,163 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $32,711,120 | 493,306 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $36,499,078 | 475,682 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $22,996,579 | 534,059 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $18,860,985 | 436,698 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,930,396 | 345,165 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||